AlphaQuest’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-111
Closed -$13.6K 821
2025
Q4
$13.6K Sell
111
-11,032
-99% -$1.34M ﹤0.01% 2137
2025
Q3
$1.24M Buy
11,143
+1,096
+11% +$125K 0.08% 346
2025
Q2
$1.11M Sell
10,047
-7,797
-44% -$830K 0.11% 267
2025
Q1
$2M Sell
17,844
-1,265
-7% -$131K 0.22% 99
2024
Q4
$1.77M Buy
19,109
+10,709
+127% +$964K 0.23% 78
2024
Q3
$704K Buy
8,400
+5,211
+163% +$398K 0.06% 517
2024
Q2
$219K Sell
3,189
-9,906
-76% -$661K 0.03% 716
2024
Q1
$959K Sell
13,095
-5,775
-31% -$444K 0.17% 201
2023
Q4
$1.53M Buy
+18,870
New +$1.47M 0.32% 51

Other funds holding GILD

AlphaQuest's GILD Position: Q1 2026 in Review

AlphaQuest sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 111 shares — an estimated $13.6K sold.

AlphaQuest first reported a position in GILD in Q4 2023 and held it in 9 quarters. The position peaked at $2M in Q1 2025. 2,329 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AlphaQuest reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 111 Gilead Sciences shares in Q1 2026, an estimated $13.6K.
  • AlphaQuest first reported a position in Gilead Sciences in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Gilead Sciences position peaked at $2M in Q1 2025.
  • 2,329 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.